LXR-targeted therapy (not specified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LXR-targeted therapy (not specified), covering 2025-09-17 to 2025-09-17. Get the full timeline:
Most recent: Clinical Trial Update: Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)